» Articles » PMID: 22869526

A Distinct Smoothened Mutation Causes Severe Cerebellar Developmental Defects and Medulloblastoma in a Novel Transgenic Mouse Model

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2012 Aug 8
PMID 22869526
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Deregulated developmental processes in the cerebellum cause medulloblastoma, the most common pediatric brain malignancy. About 25 to 30% of cases are caused by mutations increasing the activity of the Sonic hedgehog (Shh) pathway, a critical mitogen in cerebellar development. The proto-oncogene Smoothened (Smo) is a key transducer of the Shh pathway. Activating mutations in Smo that lead to constitutive activity of the Shh pathway have been identified in human medulloblastoma. To understand the developmental and oncogenic effects of two closely positioned point mutations in Smo, we characterized NeuroD2-SmoA2 mice and compared them to NeuroD2-SmoA1 mice. While both SmoA1 and SmoA2 transgenes cause medulloblastoma with similar frequencies and timing, SmoA2 mice have severe aberrations in cerebellar development, whereas SmoA1 mice are largely normal during development. Intriguingly, neurologic function, as measured by specific tests, is normal in the SmoA2 mice despite extensive cerebellar dysplasia. We demonstrate how two nearly contiguous point mutations in the same domain of the encoded Smo protein can produce striking phenotypic differences in cerebellar development and organization in mice.

Citing Articles

Epigenetic priming of neural progenitors by Notch enhances Sonic hedgehog signaling and establishes gliogenic competence.

Tran L, Shinde A, Schuster K, Sabaawy A, Dale E, Welch M bioRxiv. 2025; .

PMID: 39896669 PMC: 11785114. DOI: 10.1101/2025.01.20.633996.


Sonic hedgehog signalling pathway in CNS tumours: its role and therapeutic implications.

Wireko A, Ben-Jaafar A, Kong J, Mannan K, Sanker V, Rosenke S Mol Brain. 2024; 17(1):83.

PMID: 39568072 PMC: 11580395. DOI: 10.1186/s13041-024-01155-w.


Towards Precision Oncology: The Role of Smoothened and Its Variants in Cancer.

Nicheperovich A, Townsend-Nicholson A J Pers Med. 2022; 12(10).

PMID: 36294790 PMC: 9605185. DOI: 10.3390/jpm12101648.


Modeling Brain Tumors: A Perspective Overview of and Organoid Models.

Antonica F, Aiello G, Soldano A, Abballe L, Miele E, Tiberi L Front Mol Neurosci. 2022; 15:818696.

PMID: 35706426 PMC: 9190727. DOI: 10.3389/fnmol.2022.818696.


Sonic Hedgehog Signaling in Cerebellar Development and Cancer.

Wang W, Shiraishi R, Kawauchi D Front Cell Dev Biol. 2022; 10:864035.

PMID: 35573667 PMC: 9100414. DOI: 10.3389/fcell.2022.864035.


References
1.
Goldowitz D, Hamre K . The cells and molecules that make a cerebellum. Trends Neurosci. 1998; 21(9):375-82. DOI: 10.1016/s0166-2236(98)01313-7. View

2.
Lee H, Greene L, Mason C, Manzini M . Isolation and culture of post-natal mouse cerebellar granule neuron progenitor cells and neurons. J Vis Exp. 2009; (23). PMC: 2781826. DOI: 10.3791/990. View

3.
Taylor M, Northcott P, Korshunov A, Remke M, Cho Y, Clifford S . Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 2011; 123(4):465-72. PMC: 3306779. DOI: 10.1007/s00401-011-0922-z. View

4.
Wang V, Zoghbi H . Genetic regulation of cerebellar development. Nat Rev Neurosci. 2001; 2(7):484-91. DOI: 10.1038/35081558. View

5.
Rogers D, Fisher E, Brown S, Peters J, Hunter A, Martin J . Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome. 1997; 8(10):711-3. DOI: 10.1007/s003359900551. View